These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 552354)

  • 1. [Studies on correlation between alterations in serum sialic acid levels and remission, metastasis, and recurrence of diseases in patients with cancer (author's transl)].
    Chen YQ; Zhou YQ; Yu SY
    Zhonghua Zhong Liu Za Zhi; 1979; 1(1):29-34. PubMed ID: 552354
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum sialic acid level (SSAL) in patients with cancer or tuberculosis of the lung (author's transl)].
    Wang FL; Wang YQ; Zhang ZY; Zhao C
    Zhonghua Zhong Liu Za Zhi; 1981 Aug; 3(3):177-80. PubMed ID: 7338143
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of serum fucose, sialic acid, haptoglobine and phospholipids levels in the evolution and treatment of breast cancer.
    Kiricuta I; Bojan O; Comes R; Cristian R
    Arch Geschwulstforsch; 1979; 49(2):106-12. PubMed ID: 475547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma sialic acid alterations in neoplastic diseases.
    Dwivedi C; Dixit M; Kumar SS; Reddy H; Semenya KA; Hardy RE
    J Med; 1987; 18(5-6):323-32. PubMed ID: 3505259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulating lipid-bound sialic acid levels in patients with malignant tumors].
    Bassalyk LS; Novikov AM; Sokolova VD; Sorokin EN
    Vopr Med Khim; 1984; 30(3):124-7. PubMed ID: 6474937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum lipid-bound sialic acid as a marker in lung cancer patients].
    Iwahashi N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1599-607. PubMed ID: 2077205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical markers of tumor diathesis and early cancer.
    Tan RS; Chen YQ; Fan ZF; Liu SZ; Zhang YH
    Cancer Detect Prev; 1986; 9(1-2):145-9. PubMed ID: 3731189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative serum vascular endothelial growth factor-C (VEGF-C) levels predict recurrence in patients with esophageal cancer.
    Kimura H; Kato H; Tanaka N; Inose T; Faried A; Sohda M; Nakajima M; Fukai Y; Miyazaki T; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
    Anticancer Res; 2008; 28(1A):165-9. PubMed ID: 18383841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum levels of N-acetyl-neuraminic acid in normal subjects and patients with gastric cancer and gastric ulcer (author's transl)].
    Dávila M; Wolff C; Ugarte JM; Hoffenberg P; Rufin F; Yazigi R; Miranda J
    Rev Med Chil; 1977 Jun; 105(6):359-62. PubMed ID: 897427
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavior of serum sialic acid levels at various stages of neoplastic disease].
    Adamo V; Altavilla G; Caristi N; Chillemi S; Giacobello T; Scalisi R; Palmara D
    Minerva Med; 1985 Nov; 76(43):2067-70. PubMed ID: 4069416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of lipid-bound sialic acid levels in the diagnosis of recurrences of cancer of the rectum].
    Ozhiganov EL; Novikov AM; Bassilyk LS
    Lab Delo; 1987; (3):204-7. PubMed ID: 2438465
    [No Abstract]   [Full Text] [Related]  

  • 12. High serum soluble E-selectin levels are associated with postoperative haematogenic recurrence in esophageal squamous cell carcinoma patients.
    Shimada Y; Maeda M; Watanabe G; Imamura M
    Oncol Rep; 2003; 10(4):991-5. PubMed ID: 12792758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
    Kakari S; Stringou E; Toumbis M; Ferderigos AS; Poulaki E; Chondros K; Dema A; Kotsovoulou V; Pavlidis N
    Anticancer Res; 1991; 11(6):2107-10. PubMed ID: 1663720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of serum sialic acid in three kinds of malignant tumor and its clinical significance].
    Liang XH; Liang XM; Yi B
    Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):65-6. PubMed ID: 12934403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sialic acid and carcinoembryonic antigen (CEA) as markers of colon cancer: Preliminary report].
    Dabrowska B; Krasnodebski IW; Tadeusiak W
    Pol Tyg Lek; 1991 Nov 11-25; 46(45-47):890-1. PubMed ID: 1669462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical parameters in the comprehensive diagnosis of lung cancer].
    Liubimova NV; Khaĭlenko VA; Kushlinskiĭ NE; Davydov MI
    Vopr Onkol; 1994; 40(4-6):156-61. PubMed ID: 7785236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipid-bound serum sialic acids in the complex diagnosis of recurrences of cancer of the ovary].
    Bassalyk LS; Novikov AM; Makhova EE; Kozachenko VP
    Vestn Akad Med Nauk SSSR; 1985; (9):67-70. PubMed ID: 4060879
    [No Abstract]   [Full Text] [Related]  

  • 18. [The determination of sialic acid in cancer patients].
    Correale M; Abbate I; Gargano G; Catino A; Musci MD; Dragone CD; De Lena M
    Minerva Med; 1992; 83(7-8):427-31. PubMed ID: 1522966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of serum lipid-bound sialic acid and carcinoembryonic antigen in patients with lung cancer].
    Zhu X
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Feb; 13(1):25-7, 61. PubMed ID: 2165867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [N-acetylneuraminic acid (sialic acid) as a tumor marker in head and neck cancers].
    Fischer F; Egg G
    HNO; 1990 Oct; 38(10):361-3. PubMed ID: 2283329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.